Form 4: Agilon Health CFO Reports Routine Stock Disposition for Tax Withholding

Agilon Health, Inc.'s Chief Financial Officer, Jeffrey A. Schwaneke, reported a disposition of 46,099 shares of common stock for tax withholding purposes related to restricted stock units.

Summary

• Jeffrey A. Schwaneke, Chief Financial Officer of agilon health, inc., reported a transaction on July 1, 2025.
• The transaction involved the disposition of 46,099 shares of Common Stock at a price of $2.38 per share.
• This disposition represents shares withheld by the issuer to satisfy income tax withholding and remittance obligations related to the net settlement of restricted stock units, and it is explicitly stated not to be a sale.
• Following this transaction, Jeffrey A. Schwaneke beneficially owns 1,075,122 shares, which includes restricted stock units.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding related to equity compensation, which is a neutral event and does not indicate positive or negative sentiment about the company's performance or outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction, specifically a tax withholding event, which is common for executives receiving equity compensation. It does not provide broader industry context or trends.

Stakeholder Impact

• This transaction is a routine administrative event related to executive compensation and has minimal direct impact on shareholders, employees, customers, suppliers, or creditors beyond standard compensation practices.

Key Dates

Keywords

agilon health, AGL, Jeffrey A. Schwaneke, Chief Financial Officer, CFO, Form 4, SEC filing, stock transaction, tax withholding, restricted stock units, RSU, insider transaction